Cantor Fitzgerald Brokers Lower Earnings Estimates for BCAX
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for shares of Bicara Therapeutics in a research note issued to investors on Wednesday, May 14th. Cantor Fitzgerald analyst E. Schmidt now forecasts that the company will post earnings per share of ($2.11) for the […]
